Contact this trialFirst, we need to learn more about you.
Virus Therapy
VG161 + Nivolumab for Liver Cancer
Recruiting1 awardPhase 2
Phoenix, Arizona
This trial tests VG161 injections and Nivolumab IV drips in patients with liver cancers. VG161 aims to directly attack cancer cells, while Nivolumab boosts the immune system to help it fight the cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service